BibTex format
@article{Ryerson:2025:10.1183/13993003.00158-2025,
author = {Ryerson, CJ and Adegunsoye, A and Piciucchi, S and Hariri, LP and Khor, YH and Wijsenbeek, MS and Wells, AU and Sharma, A and Cooper, WA and Antoniou, K and Borie, R and Fabre, A and Inoue, Y and Johannson, K and Johkoh, T and Kawano-Dourado, L and Kazerooni, E and Maher, TM and Molyneaux, PL and Protti, R and Ravaglia, C and Renzoni, EA and Saito-Koyama, R and Sverzellati, N and Walsh, SLF and Wolters, P and Yang, S-R and Travis, W and Nicholson, AG},
doi = {10.1183/13993003.00158-2025},
journal = {Eur Respir J},
title = {Update of the international multidisciplinary classification of the interstitial pneumonias: an ERS/ATS statement.},
url = {http://dx.doi.org/10.1183/13993003.00158-2025},
volume = {66},
year = {2025}
}
RIS format (EndNote, RefMan)
TY - JOUR
AB - BACKGROUND: The 2013 American Thoracic Society/European Respiratory Society statement on the classification of the idiopathic interstitial pneumonias described six major and two rare subtypes of idiopathic interstitial pneumonia, as well as recognising unclassifiable disease. OBJECTIVE: The objective of this statement is to update the 2013 classification of interstitial pneumonia. METHODS: Five co-chairs identified a committee of 32 experts in the field, as well as two individuals with lived experience. Creation of the document was supported by a series of video meetings, first including the full committee and then subgroups assigned to draft specific sections of the document. The classification scheme was developed by consensus. RESULTS: The multidisciplinary committee of experts identified four major advances to the classification of interstitial pneumonia: 1) expansion beyond idiopathic interstitial pneumonias to also include secondary causes; 2) identification of new subcategories and updated terms, including addition of bronchiolocentric interstitial pneumonia as a major pattern as well as changing from acute interstitial pneumonia to idiopathic diffuse alveolar damage and desquamative interstitial pneumonia to alveolar macrophage pneumonia; 3) subclassification of interstitial and alveolar filling disorders, with interstitial disorders further subclassified as fibrotic versus non-fibrotic; and 4) consideration of diagnostic confidence in patient evaluation and management. The committee also provided a comprehensive update on the status of potential molecular tools and identified future research priorities. CONCLUSIONS: This update builds upon the previous classification approach by describing major advances in the classification of interstitial pneumonia over the past decade.
AU - Ryerson,CJ
AU - Adegunsoye,A
AU - Piciucchi,S
AU - Hariri,LP
AU - Khor,YH
AU - Wijsenbeek,MS
AU - Wells,AU
AU - Sharma,A
AU - Cooper,WA
AU - Antoniou,K
AU - Borie,R
AU - Fabre,A
AU - Inoue,Y
AU - Johannson,K
AU - Johkoh,T
AU - Kawano-Dourado,L
AU - Kazerooni,E
AU - Maher,TM
AU - Molyneaux,PL
AU - Protti,R
AU - Ravaglia,C
AU - Renzoni,EA
AU - Saito-Koyama,R
AU - Sverzellati,N
AU - Walsh,SLF
AU - Wolters,P
AU - Yang,S-R
AU - Travis,W
AU - Nicholson,AG
DO - 10.1183/13993003.00158-2025
PY - 2025///
TI - Update of the international multidisciplinary classification of the interstitial pneumonias: an ERS/ATS statement.
T2 - Eur Respir J
UR - http://dx.doi.org/10.1183/13993003.00158-2025
UR - https://www.ncbi.nlm.nih.gov/pubmed/40774805
VL - 66
ER -